Literature DB >> 12174533

Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Rolf Leibbrand1, Ulrich Cuntz, Wolfgang Hiller.   

Abstract

The purpose was to investigate the reliability and factorial structure of the Gastro-Questionnaire for the screening and psychometric measurement of functional gastrointestinal disorders (FGDs). The questionnaire contains 27 gastrointestinal symptom items drawn from the Rome-II criteria, which are rated by frequency and severity, as well as some items to exclude organic diseases. The questionnaire was administered to 259 normal participants and to 69 participants of the annual German meeting of patients with irritable bowel syndrome. Reliability was good (Cronbach's alpha for frequency and severity items: alpha = .86 and alpha = .87). Factor analysis yielded a six-factor solution explaining 60.7% of the variance. Diagnostic frequencies ranged from 32.8% to 100% for FGDs in general, from 1.3% to 76.8% for irritable bowel syndrome, and from 7.0% to 100% for functional dyspepsia, depending on samples and symptom definitions. The Gastro-Questionnaire is a very economic, reliable, and content-valid instrument for the assessment of FGDs.

Entities:  

Mesh:

Year:  2002        PMID: 12174533     DOI: 10.1207/s15327558ijbm0902_06

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  24 in total

Review 1.  [Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases].

Authors:  J Hotz; P Enck; H Goebell; I Heymann-Mönnikes; G Holtmann; P Layer
Journal:  Z Gastroenterol       Date:  1999-08       Impact factor: 2.000

Review 2.  Functional disorders of the anus and rectum.

Authors:  W E Whitehead; A Wald; N E Diamant; P Enck; J H Pemberton; S S Rao
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

Authors:  K W Heaton; L J O'Donnell; F E Braddon; R A Mountford; A O Hughes; P J Cripps
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study.

Authors:  P Boyce; J Gilchrist; N J Talley; D Rose
Journal:  Aust N Z J Psychiatry       Date:  2000-04       Impact factor: 5.744

5.  Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome.

Authors:  R C Smith; D S Greenbaum; J B Vancouver; R C Henry; M A Reinhart; R B Greenbaum; H A Dean; J E Mayle
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples.

Authors:  W E Whitehead; M D Crowell; L Bosmajian; A Zonderman; P T Costa; C Benjamin; J C Robinson; B R Heller; M M Schuster
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

7.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

8.  Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates.

Authors:  G F Longstreth; G Wolde-Tsadik
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

9.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

10.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

Authors:  N J Talley; P Boyce; M Jones
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

View more
  10 in total

1.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

3.  How are you feeling?: A personalized methodology for predicting mental states from temporally observable physical and behavioral information.

Authors:  Suppawong Tuarob; Conrad S Tucker; Soundar Kumara; C Lee Giles; Aaron L Pincus; David E Conroy; Nilam Ram
Journal:  J Biomed Inform       Date:  2017-02-15       Impact factor: 6.317

4.  An algorithm for defining somatization in children.

Authors:  Inna Postilnik; Howard D Eisman; Rebecca Price; Joshua Fogel
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-05

5.  Endocrine dysregulation in women with irritable bowel syndrome according to Rome II criteria.

Authors:  Charlotte Markert; Kerstin Suarez-Hitz; Ulrike Ehlert; Urs M Nater
Journal:  J Behav Med       Date:  2016-02-05

6.  Distress criterion influences prevalence rates of functional gastrointestinal disorders.

Authors:  Charlotte Markert; Kerstin Suarez-Hitz; Ulrike Ehlert; Urs M Nater
Journal:  BMC Gastroenterol       Date:  2014-12-18       Impact factor: 3.067

7.  Personal relative deprivation associated with functional disorders via stress: An examination of fibromyalgia and gastrointestinal symptoms.

Authors:  Shadi Beshai; Sanju Mishra; Sandeep Mishra; R Nicholas Carleton
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

8.  The effects of polyunsaturated fatty acid (PUFA) administration on the microbiome-gut-brain axis in adolescents with anorexia nervosa (the MiGBAN study): study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial.

Authors:  Jochen Seitz; Beate Herpertz-Dahlmann; Lara Keller; Astrid Dempfle; Brigitte Dahmen; Samira Schreiber; Roger A H Adan; Nadia Andrea Andreani; Unna N Danner; Albrecht Eisert; Sergueï Fetissov; Florian Ph S Fischmeister; Andreas Karwautz; Kerstin Konrad; Karlijn L Kooij; Stefanie Trinh; Benny van der Vijgh; Annemarie A van Elburg; Michael Zeiler; John Baines
Journal:  Trials       Date:  2022-07-05       Impact factor: 2.728

9.  Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa.

Authors:  Ulrich Cuntz; Paul Enck; Erich Frühauf; Peter Lehnert; Rudolf L Riepl; Manfred M Fichter; Bärbel Otto
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

10.  Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints.

Authors:  Isabelle Mack; Ulrich Cuntz; Claudia Grämer; Sabrina Niedermaier; Charlotte Pohl; Andreas Schwiertz; Kurt Zimmermann; Stephan Zipfel; Paul Enck; John Penders
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.